Abstract
Felix Tubin, Alex O. Esemezie, Leba M. Sarkis, Chong Yao, Sharon Tzelnick, Christopher W. Noel, David P. Goldstein, Ezra Hahn, Andrew McPartlin, Scott V. Bratman, John R. de Almeida
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Functional outcomes after TORS for oropharyngeal cancer: a systematic review
2015
Oncologic outcomes after transoral robotic surgery: a multi-institutional study
10.1001/jamaoto.2015.1508 · 2015
Differences in functional and survival outcomes between patients receiving primary surgery vs chemoradiation therapy for treatment of T1-T2 oropharyngeal squamous cell carcinoma
10.1001/jamaoto.2023.1944 · 2023
The effect of the surgical margins on the outcome of patients with head and neck squamous cell carcinoma: single institution experience
2012
The significance of “positive” margins in surgically resected epidermoid carcinomas
10.1002/hed.2890010203 · 1978
Determination of posterolateral oropharyngeal wall thickness and the potential implications for transoral surgical margins in tonsil cancer
10.1002/hed.26693 · 2021
Impact of margins on outcomes in HPV-related oropharyngeal squamous cell carcinoma treated with surgery only
10.1002/ohn.1213 · 2025
Margin status and recurrence in surgically treated patients with HPV + oropharyngeal cancer
10.1002/lary.32091 · 2025
Specimen-based resection margins and local control during transoral robotic surgery for oropharyngeal HPV-mediated squamous cell carcinoma
10.1159/000527369 · 2023
Transoral robotic surgery without adjuvant therapy: a systematic review and meta-analysis of the association between surgical margins and local recurrence
10.1016/j.oraloncology.2023.106610 · 2023
A systematic review and meta-analysis of margins in transoral surgery for oropharyngeal carcinoma
10.1016/j.oraloncology.2019.09.017 · 2019
Surgical margin determination in the Era of HPV ‐positive oropharyngeal cancer
10.1002/lary.29533 · 2021
Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: national cancer data base
10.1002/cncr.29938 · 2016
Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311)
10.1200/jco.21.01752 · 2022
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
10.1186/s12885-015-1598-x · 2015
Long-term follow-up of E3311, an ECOG-ACRIN cancer research group phase II trial of transoral surgery and risk-based adjuvant treatment in human papillomavirus-initiated oropharynx cancer
10.1200/jco-24-02550 · 2025
The effect of tumor margin status on progression-free survival (PFS) in patients with oropharyngeal squamous cell carcinoma (OPSCC) after transoral robotic surgery (TORS)
10.1016/j.ijrobp.2022.07.1389 · 2022
“Close then Clear” margins in transoral resection of p16+ oropharyngeal squamous cell carcinoma
10.1002/ohn.70032 · 2025
Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: influence of resection margins on oncological outcomes
10.1016/j.oraloncology.2022.105909 · 2022
Oropharyngeal carcinoma treated with surgery alone: outcomes and predictors of failure
10.1177/00034894211021287 · 2022
Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control
10.1001/archoto.2012.1166 · 2012
Diagnostic accuracy of intraoperative margin assessment techniques in surgery for head and neck squamous cell carcinoma: a meta-analysis
10.1016/j.oraloncology.2023.106419 · 2023
Use of intraoperative frozen section to assess surgical margins in HPV-related oropharyngeal carcinoma
10.1001/jamaoto.2024.4869 · 2025
Frozen section evaluation of margin status in primary squamous cell carcinomas of the head and neck: a correlation study of frozen section and final diagnoses
10.1007/s12105-017-0846-6 · 2018
Defining the prevalence and prognostic value of perineural invasion and angiolymphatic invasion in human papillomavirus-positive oropharyngeal carcinoma
10.1001/jamaoto.2017.2019 · 2017
NCCN guidelines® insights: head and neck cancers Version 12022
10.6004/jnccn.2022.0016 · 2022
Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: importance of nodal count in survival
10.1016/j.oraloncology.2020.104770 · 2020
Transoral robotic surgery in the multidisciplinary care of patients with oropharyngeal squamous cell carcinoma: ASCO guideline
10.1200/jco-24-02755 · 2025
A phase 2 trial of alternative volumes of oropharyngeal irradiation for de-intensification (AVOID): omission of the resected primary tumor bed after transoral robotic surgery for human papilloma virus-related squamous cell carcinoma of the oropharynx
10.1016/j.ijrobp.2019.11.021 · 2020
Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer
10.1200/jco.19.02444 · 2020
Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer
10.1158/1078-0432.ccr-19-0211 · 2019
Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma
10.1158/1078-0432.ccr-22-0562 · 2022
Circulating tumor HPV DNA for surveillance of HPV-positive oropharyngeal squamous cell carcinoma: a narrative review
10.1001/jamaoncol.2023.4042 · 2023
Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation
10.1016/j.oraloncology.2021.105332 · 2021
Postoperative human papilloma virus circulating tumor DNA guided adjuvant therapy for human papilloma virus-related oropharyngeal carcinoma (PATH Study)
10.1016/j.ijrobp.2025.09.044 · 2026
Postoperative human papilloma virus circulating tumor DNA guided adjuvant therapy for human papilloma virus-related oropharyngeal carcinoma (PATH Study)
10.1016/j.ijrobp.2025.09.044 · doi-reference
Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation
10.1016/j.oraloncology.2021.105332 · doi-reference
Circulating tumor HPV DNA for surveillance of HPV-positive oropharyngeal squamous cell carcinoma: a narrative review
10.1001/jamaoncol.2023.4042 · doi-reference
Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma
10.1158/1078-0432.ccr-22-0562 · doi-reference
Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer
10.1158/1078-0432.ccr-19-0211 · doi-reference
Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer
10.1200/jco.19.02444 · doi-reference
A phase 2 trial of alternative volumes of oropharyngeal irradiation for de-intensification (AVOID): omission of the resected primary tumor bed after transoral robotic surgery for human papilloma virus-related squamous cell carcinoma of the oropharynx
10.1016/j.ijrobp.2019.11.021 · doi-reference
Transoral robotic surgery in the multidisciplinary care of patients with oropharyngeal squamous cell carcinoma: ASCO guideline
10.1200/jco-24-02755 · doi-reference
Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: importance of nodal count in survival
10.1016/j.oraloncology.2020.104770 · doi-reference
NCCN guidelines® insights: head and neck cancers Version 12022
10.6004/jnccn.2022.0016 · doi-reference
Defining the prevalence and prognostic value of perineural invasion and angiolymphatic invasion in human papillomavirus-positive oropharyngeal carcinoma
10.1001/jamaoto.2017.2019 · doi-reference
Frozen section evaluation of margin status in primary squamous cell carcinomas of the head and neck: a correlation study of frozen section and final diagnoses
10.1007/s12105-017-0846-6 · doi-reference
Use of intraoperative frozen section to assess surgical margins in HPV-related oropharyngeal carcinoma
10.1001/jamaoto.2024.4869 · doi-reference
Diagnostic accuracy of intraoperative margin assessment techniques in surgery for head and neck squamous cell carcinoma: a meta-analysis
10.1016/j.oraloncology.2023.106419 · doi-reference
Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control
10.1001/archoto.2012.1166 · doi-reference
Oropharyngeal carcinoma treated with surgery alone: outcomes and predictors of failure
10.1177/00034894211021287 · doi-reference
Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: influence of resection margins on oncological outcomes
10.1016/j.oraloncology.2022.105909 · doi-reference
“Close then Clear” margins in transoral resection of p16+ oropharyngeal squamous cell carcinoma
10.1002/ohn.70032 · doi-reference
The effect of tumor margin status on progression-free survival (PFS) in patients with oropharyngeal squamous cell carcinoma (OPSCC) after transoral robotic surgery (TORS)
10.1016/j.ijrobp.2022.07.1389 · doi-reference
Long-term follow-up of E3311, an ECOG-ACRIN cancer research group phase II trial of transoral surgery and risk-based adjuvant treatment in human papillomavirus-initiated oropharynx cancer
10.1200/jco-24-02550 · doi-reference
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
10.1186/s12885-015-1598-x · doi-reference
Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311)
10.1200/jco.21.01752 · doi-reference
Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: national cancer data base
10.1002/cncr.29938 · doi-reference
Surgical margin determination in the Era of HPV ‐positive oropharyngeal cancer
10.1002/lary.29533 · doi-reference
A systematic review and meta-analysis of margins in transoral surgery for oropharyngeal carcinoma
10.1016/j.oraloncology.2019.09.017 · doi-reference
Transoral robotic surgery without adjuvant therapy: a systematic review and meta-analysis of the association between surgical margins and local recurrence
10.1016/j.oraloncology.2023.106610 · doi-reference
Specimen-based resection margins and local control during transoral robotic surgery for oropharyngeal HPV-mediated squamous cell carcinoma
10.1159/000527369 · doi-reference
Margin status and recurrence in surgically treated patients with HPV + oropharyngeal cancer
10.1002/lary.32091 · doi-reference
Impact of margins on outcomes in HPV-related oropharyngeal squamous cell carcinoma treated with surgery only
10.1002/ohn.1213 · doi-reference
Determination of posterolateral oropharyngeal wall thickness and the potential implications for transoral surgical margins in tonsil cancer
10.1002/hed.26693 · doi-reference
The significance of “positive” margins in surgically resected epidermoid carcinomas
10.1002/hed.2890010203 · doi-reference
Differences in functional and survival outcomes between patients receiving primary surgery vs chemoradiation therapy for treatment of T1-T2 oropharyngeal squamous cell carcinoma
10.1001/jamaoto.2023.1944 · doi-reference
Oncologic outcomes after transoral robotic surgery: a multi-institutional study
10.1001/jamaoto.2015.1508 · doi-reference